Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inh...

by Abtahi, S., Croes, S., de Vries, F., Dingemans, A.-M.C, Driessen, J.H.M, Klungel, O.H, Souverein, P., van Geel, R., van Veelen, A.
Published 2022

Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis

by Bero, L., De Bruin, M.L, Dormuth, C.R, Gnjidic, D., Hallgreen, C.E, Kemp-Casey, A., Lexchin, J., Lopert, R., Mangin, D., Mintzes, B., Morrow, R.L, Ofori-Asenso, R., Pearson, S.-A, Perry, L.T, Puil, L., Roughead, E.E, Sarpatwari, A., Sketris, I., Souverein, P.C
Published 2022